“…In this context, isoxazole substituted pyrroles are present as the core substructure in some meaningful compounds, such as isoxazolylpyrroles I and II are inhibitors to oral and mouth cancer cell and the activators to cellular tumor antigen p53 [ 2 , 3 ]. Isoxazolylpyrroles III and IV are the key intermediates in the synthesis of bioactive prodiginines natural products and their congeners, and the precursors structures of phosphodiesterase inhibitors PDE-I and PDE-II, which inhibitory activity toward cyclic adenosine-3′,5′-monophosphate phosphodiesterase, respectively [ 4 , 5 ]. Isoxazolylpyrroles V is a receptor for recognition and sensing purposes in aprotic solvents [ 6 , 7 ].…”